Abstract: Arbutin-containing compositions are useful for topical application to provide enhanced luminosity, brightening or lightening to the skin of a user and are at least 85% as efficacious (with regard to skin lightening, when used alone or in a system as measured by Chromameter® b* parameter values) as substantially corresponding compositions containing hydroquinone in an mount from about the same molar amount to about 1.5 times the molar amount of arbutin.
Abstract: Arbutin-containing compositions are useful for topical application to provide enhanced luminosity, brightening or lightening to the skin of a user and are at least 85% as efficacious (with regard to skin lightening, when used alone or in a system as measured by Chromameter® b* parameter values) as substantially corresponding compositions containing hydroquinone in an amount from about the same molar amount to about 1.5 times the molar amount of arbutin.
Abstract: Drug delivery systems and a treatment regimen that improves percutaneous absorption of topically applied drug or active agent is described. The method generally has three steps including pre-treating the surface of skin in need thereof; applying an active ingredient to the skin; and applying a post treatment agent to the skin. Pre-treatment agents, drugs and active ingredients, as well as post treatment agents are described.
Type:
Grant
Filed:
December 1, 2005
Date of Patent:
April 7, 2015
Assignee:
OMP, Inc.
Inventors:
Jose E. Ramirez, Austin McNamara, Judy Hattendorf, Steve Goldner
Abstract: A treatment regimen for treating skin subject to skin cancer treatments involves the application of supplemental composition(s) such as preparatory composition(s), protective composition(s), and combinations thereof, and a corrective composition.
© 2025 Justia
